Clarivate Introduces Cortellis Supply Chain Network™, a Revolutionary Digital Partnering Solution

Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) has launched the Cortellis Supply Chain Network™, aimed at enhancing supply chain efficiency in the biopharma sector. This platform connects over 70,000 buyers and sellers, facilitating better identification of partners and management of procurement processes. The initiative addresses vulnerabilities exposed by the COVID-19 pandemic, which highlighted the need for greater supply chain transparency. By providing continuously updated manufacturing data and insights on supply risks, the network aims to ensure more accessible therapies for patients.

Positive

• Launch of the Cortellis Supply Chain Network enhances access to over 70,000 companies.
• Addresses critical supply chain vulnerabilities revealed by the COVID-19 pandemic.
• Provides continuously updated data, improving efficiency in procurement and sourcing.
• Aims to ensure better therapy accessibility through improved supply chain connections.

Negative

• None.

LONDON, July 21, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of the Cortellis Supply Chain Network™, a part of the Cortellis suite of life science intelligence solutions. The solution supports generics companies, Active Pharmaceutical Ingredients (API) manufacturers, fine chemical manufacturers, excipient manufacturers, raw materials suppliers, and biopharma in their pursuit to maintain a steady supply chain -- ultimately making therapies easily accessible to all patients. The Cortellis Supply Chain Network can connect more than 70K+ companies – buyers and sellers – with more data added by the expert research team and directly by users every day.

Vulnerabilities in pharma supply chains have been an increasingly important focus in the industry with the coronavirus pandemic further exposing shortcomings within the global supply chain.¹ These vulnerabilities have led key industry players, from manufacturers to government bodies, to proactively monitor and mitigate supply risk. Identifying new suppliers and contacts within generics and biopharma companies to provide APIs or excipients for drug manufacturing can often be challenging for procurement, sourcing teams and manufacturers. Buyers find it difficult to keep track of new manufacturers and existing manufacturers' expansion into new capabilities – and sellers find it challenging to stand out from the competition. 

Cortellis Supply Chain Network provides buyers and sellers with a secure marketplace that allows them to identify potential partners, connect with the right point of contact, and efficiently manage all steps, from quotation to finalizing the deal. With an increased demand for more accessible therapies, the network will enable industry players to build robust supply chains and identify alternate sources during unprecedented times.

Identifying alternate API sources and other critical ingredients to prevent manufacturing delays caused by unexpected events, can help build a resilient supply chain. Cortellis Supply Chain Network provides access to continuously updated manufacturing data, saving users time in confidently assessing potential partners. High-quality product data is paired with primary research on API manufacturers to verify their pipeline and manufacturing capabilities. Users can monitor and manage supply risk with insights on the latest inspections, warning letters, GMP Certificates, supply issues and more. In addition, it provides users with personalized updates, documentation, and alerts to support overall supply transparency in the industry.

Keith Collier SVP Product - Science, Clarivate, said: "The COVID-19 pandemic put a spotlight on drug supply chains across the globe, especially for critical and essential medicines. Although the generics industry has long identified an over-reliance on China and India to supply APIs and key starting materials, the pandemic highlighted a critical need for greater transparency and reliable supply chains.  As an organization committed to supporting customers across the entire drug, device and medical technology lifecycles to drive clinical and commercial success, Clarivate developed the Cortellis Supply Chain Network, which aims to open communication channels between manufacturers, provide insights on supply capabilities or vulnerabilities and facilitate deal-making."

The Cortellis Supply Chain Network is powered by the Clarivate Research Intelligence Cloud™ -- allowing more comprehensive research and analysis during market assessment activities. The Cortellis Supply Chain Network is just one of the many investments Clarivate has made and will continue to make – expanding and enhancing its suite of life science intelligence solutions in response to customer needs.

To learn more, visit the Cortellis Supply Chain Network here.

About Clarivate

Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.

Media Contact
Catherine Daniel
media.enquiries@clarivate.com

¹ Fitzhugh, Michael. "Experts seek path to building a more resilient drug supply chain." BioWorld, https://www.bioworld.com/articles/506084-experts-seek-path-to-building-a-more-resilient-drug-supply-chain?v=preview. April 19, 2021.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-introduces-cortellis-supply-chain-network-a-revolutionary-digital-partnering-solution-301337917.html

SOURCE Clarivate Plc

FAQ

What is the Cortellis Supply Chain Network launched by Clarivate?

The Cortellis Supply Chain Network is a digital platform designed to enhance supply chain efficiency by connecting over 70,000 companies in the biopharma sector.

How does the Cortellis Supply Chain Network improve supply chain management?

The network provides continuously updated data and insights, allowing users to identify partners, manage procurement processes, and monitor supply risks effectively.

What issues does the Cortellis Supply Chain Network address?

It addresses vulnerabilities exposed during the COVID-19 pandemic, such as the need for greater transparency and reliable supply chains in the biopharma industry.

How does Clarivate support the pharmaceutical industry?

Clarivate aims to support the pharmaceutical industry by providing solutions that enhance the lifecycle of innovation and improve supply chain management.

What benefits does the Cortellis Supply Chain Network offer to users?

Users benefit from easy identification of potential partners, access to high-quality product data, and tools to manage supply risks and increase therapy accessibility.